INVETX, INC.
9Patents
9Active
9Granted
57Portfolio score
Filing activity: Jan 2, 2020 → Jan 23, 2024
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11498953B2 | Compositions for increasing half-life of a therapeutic agent in felines and methods of use | Chemistry; Metallurgy | 2 | Active |
| US11739135B2 | Compositions for increasing half-life of a therapeutic agent in felines and methods of use | Chemistry; Metallurgy | 1 | Active |
| US12378308B2 | Anti-NGF antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11542333B2 | Compositions for increasing half-life of a therapeutic agent in canines and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12110322B2 | Anti-NGF antibodies and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US11434276B2 | Polypeptides with altered binding to neonatal Fc receptor (FcRn) and methods of use | Chemistry; Metallurgy | 0 | Active |
| US11548949B2 | Compositions for increasing half-life of a therapeutic agent in canines and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12344650B2 | Compositions for increasing half-life of a therapeutic agent in felines and methods of use | Chemistry; Metallurgy | 0 | Active |
| US12103961B2 | Compositions for increasing half-life of a therapeutic agent in livestock animals and methods of use | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.